SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (162)2/29/2008 12:45:39 AM
From: tuck  Read Replies (1) of 210
 
I don't know if I am crying wolf here, but thought I'd make a note of it . . . In what might be good news for Infinity -- but then again maybe is really bad news for Infinity -- Kosan today dropped their promising 2nd generation oral Hsp90 inhibitor. They cited several reasons, but the one that sticks out is that they came across "new information" regarding the IP of their formulation. In other words, somebody beat them to the patent office. Infinity is even more reliant on their Hsp90 program than Kosan, so it would behoove Infinity investors to reassure themselves that Infinity isn't going to have a similar issue. I posted about this on the Kosan thread here:

Message 24356501

Note Infinity only has one patent app here (I haven't searched the issued ones), the link to which is in the above Kosan post. Conforma, now part of Biogen, has 17. Thus I suspect it is Biogen that has the IP stumbling block that tripped up Kosan. If I held Infinity, or was planning to, I'd be asking IR about this issue. I have traded in and out of Infinity for modest gains a couple of times. I was watching for an entry in the low $7s. Now I'm not going to touch it with a ten foot pole, until I have this answer.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News